Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2025-12-26 @ 12:23 AM
Study NCT ID:
NCT04980495
Status:
COMPLETED
Last Update Posted:
2025-11-05
First Post:
2021-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-19
First Submit QC Date:
None
Study First Post Date:
2021-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-04-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-04
Last Update Post Date:
2025-11-05
Last Update Post Date Type:
ESTIMATED